Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

HIV-1 inhibitory properties of eCD4-Igmim2 determined using an Env-mediated membrane fusion assay.

Yang E, Gardner MR, Zhou AS, Farzan M, Arvin AM, Oliver SL.

PLoS One. 2018 Oct 25;13(10):e0206365. doi: 10.1371/journal.pone.0206365. eCollection 2018.

2.

APC2 associates with the actin cortex through a multipart mechanism to regulate cortical actin organization and dynamics in the Drosophila ovary.

Molinar-Inglis O, Oliver SL, Rudich P, Kunttas E, McCartney BM.

Cytoskeleton (Hoboken). 2018 Jul;75(7):323-335. doi: 10.1002/cm.21471. Epub 2018 Sep 21.

PMID:
30019417
3.

Varicella-Zoster Virus Glycoproteins: Entry, Replication, and Pathogenesis.

Oliver SL, Yang E, Arvin AM.

Curr Clin Microbiol Rep. 2016 Dec;3(4):204-215. doi: 10.1007/s40588-016-0044-4. Epub 2016 Sep 9.

4.

The Glycoprotein B Cytoplasmic Domain Lysine Cluster Is Critical for Varicella-Zoster Virus Cell-Cell Fusion Regulation and Infection.

Yang E, Arvin AM, Oliver SL.

J Virol. 2016 Dec 16;91(1). pii: e01707-16. doi: 10.1128/JVI.01707-16. Print 2017 Jan 1.

5.

Dysregulated Glycoprotein B-Mediated Cell-Cell Fusion Disrupts Varicella-Zoster Virus and Host Gene Transcription during Infection.

Oliver SL, Yang E, Arvin AM.

J Virol. 2016 Dec 16;91(1). pii: e01613-16. doi: 10.1128/JVI.01613-16. Print 2017 Jan 1.

6.

Role for the αV Integrin Subunit in Varicella-Zoster Virus-Mediated Fusion and Infection.

Yang E, Arvin AM, Oliver SL.

J Virol. 2016 Jul 27;90(16):7567-78. doi: 10.1128/JVI.00792-16. Print 2016 Aug 15.

7.

A site of varicella-zoster virus vulnerability identified by structural studies of neutralizing antibodies bound to the glycoprotein complex gHgL.

Xing Y, Oliver SL, Nguyen T, Ciferri C, Nandi A, Hickman J, Giovani C, Yang E, Palladino G, Grose C, Uematsu Y, Lilja AE, Arvin AM, Carfí A.

Proc Natl Acad Sci U S A. 2015 May 12;112(19):6056-61. doi: 10.1073/pnas.1501176112. Epub 2015 Apr 27.

8.

The cytoplasmic domain of varicella-zoster virus glycoprotein H regulates syncytia formation and skin pathogenesis.

Yang E, Arvin AM, Oliver SL.

PLoS Pathog. 2014 May 29;10(5):e1004173. doi: 10.1371/journal.ppat.1004173. eCollection 2014 May.

9.

Molecular mechanisms of varicella zoster virus pathogenesis.

Zerboni L, Sen N, Oliver SL, Arvin AM.

Nat Rev Microbiol. 2014 Mar;12(3):197-210. doi: 10.1038/nrmicro3215. Epub 2014 Feb 10. Review.

10.

Using the iPlant collaborative discovery environment.

Oliver SL, Lenards AJ, Barthelson RA, Merchant N, McKay SJ.

Curr Protoc Bioinformatics. 2013 Jun;Chapter 1:Unit1.22. doi: 10.1002/0471250953.bi0122s42.

PMID:
23749752
11.

ORF11 protein interacts with the ORF9 essential tegument protein in varicella-zoster virus infection.

Che X, Oliver SL, Reichelt M, Sommer MH, Haas J, Roviš TL, Arvin AM.

J Virol. 2013 May;87(9):5106-17. doi: 10.1128/JVI.00102-13. Epub 2013 Feb 20.

12.

An immunoreceptor tyrosine-based inhibition motif in varicella-zoster virus glycoprotein B regulates cell fusion and skin pathogenesis.

Oliver SL, Brady JJ, Sommer MH, Reichelt M, Sung P, Blau HM, Arvin AM.

Proc Natl Acad Sci U S A. 2013 Jan 29;110(5):1911-6. doi: 10.1073/pnas.1216985110. Epub 2013 Jan 15.

13.

Structure-function analysis of varicella-zoster virus glycoprotein H identifies domain-specific roles for fusion and skin tropism.

Vleck SE, Oliver SL, Brady JJ, Blau HM, Rajamani J, Sommer MH, Arvin AM.

Proc Natl Acad Sci U S A. 2011 Nov 8;108(45):18412-7. doi: 10.1073/pnas.1111333108. Epub 2011 Oct 24.

14.

Disruption of PML nuclear bodies is mediated by ORF61 SUMO-interacting motifs and required for varicella-zoster virus pathogenesis in skin.

Wang L, Oliver SL, Sommer M, Rajamani J, Reichelt M, Arvin AM.

PLoS Pathog. 2011 Aug;7(8):e1002157. doi: 10.1371/journal.ppat.1002157. Epub 2011 Aug 25.

15.

Mutagenesis of varicella-zoster virus glycoprotein I (gI) identifies a cysteine residue critical for gE/gI heterodimer formation, gI structure, and virulence in skin cells.

Oliver SL, Sommer MH, Reichelt M, Rajamani J, Vlaycheva-Beisheim L, Stamatis S, Cheng J, Jones C, Zehnder J, Arvin AM.

J Virol. 2011 May;85(9):4095-110. doi: 10.1128/JVI.02596-10. Epub 2011 Feb 23.

16.

Identification and functional characterization of the Varicella zoster virus ORF11 gene product.

Che X, Oliver SL, Sommer MH, Rajamani J, Reichelt M, Arvin AM.

Virology. 2011 Mar 30;412(1):156-66. doi: 10.1016/j.virol.2010.12.055. Epub 2011 Jan 26.

17.

Semiquantitative histopathology and 3D magnetic resonance microscopy as collaborative platforms for tissue identification and comparison within teratomas derived from pedigreed primate embryonic stem cells.

Castro CA, Ben-Yehudah A, Ozolek JA, Mills PH, Redinger CJ, Mich-Basso JD, McFarland DA, Oliver SL, Ahrens ET, Schatten G.

Stem Cell Res. 2010 Nov;5(3):201-11. doi: 10.1016/j.scr.2010.07.005. Epub 2010 Aug 6.

18.

mTOR-mediated activation of p70 S6K induces differentiation of pluripotent human embryonic stem cells.

Easley CA 4th, Ben-Yehudah A, Redinger CJ, Oliver SL, Varum ST, Eisinger VM, Carlisle DL, Donovan PJ, Schatten GP.

Cell Reprogram. 2010 Jun;12(3):263-73. doi: 10.1089/cell.2010.0011.

19.

Human antibody responses to bovine (Newbury-2) norovirus (GIII.2) and association to histo-blood group antigens.

Vildevall M, Grahn A, Oliver SL, Bridger JC, Charpilienne A, Poncet D, Larson G, Svensson L.

J Med Virol. 2010 Jul;82(7):1241-6. doi: 10.1002/jmv.21776.

PMID:
20513091
20.

Anti-glycoprotein H antibody impairs the pathogenicity of varicella-zoster virus in skin xenografts in the SCID mouse model.

Vleck SE, Oliver SL, Reichelt M, Rajamani J, Zerboni L, Jones C, Zehnder J, Grose C, Arvin AM.

J Virol. 2010 Jan;84(1):141-52. doi: 10.1128/JVI.01338-09.

21.

Mutagenesis of varicella-zoster virus glycoprotein B: putative fusion loop residues are essential for viral replication, and the furin cleavage motif contributes to pathogenesis in skin tissue in vivo.

Oliver SL, Sommer M, Zerboni L, Rajamani J, Grose C, Arvin AM.

J Virol. 2009 Aug;83(15):7495-506. doi: 10.1128/JVI.00400-09. Epub 2009 May 27.

22.

Comparison of the efficacy of rotavirus VLP vaccines to a live homologous rotavirus vaccine in a pig model of rotavirus disease.

El-Attar L, Oliver SL, Mackie A, Charpilienne A, Poncet D, Cohen J, Bridger JC.

Vaccine. 2009 May 21;27(24):3201-8. doi: 10.1016/j.vaccine.2009.03.043. Epub 2009 Apr 7.

PMID:
19446192
23.

Establishment and characterization of baboon embryonic stem cell lines: an Old World Primate model for regeneration and transplantation research.

Simerly CR, Navara CS, Castro CA, Turpin JC, Redinger CJ, Mich-Basso JD, Jacoby ES, Grund KJ, McFarland DA, Oliver SL, Ben-Yehudah A, Carlisle DL, Frost P, Penedo C, Hewitson L, Schatten G.

Stem Cell Res. 2009 May;2(3):178-87. doi: 10.1016/j.scr.2009.02.004. Epub 2009 Feb 21.

24.

Heterogeneity in the capsid protein of bovine enteric caliciviruses belonging to a new genus.

D'Mello F, Jervis SM, Edwards PM, Oliver SL, Bridger JC.

Virology. 2009 Apr 25;387(1):109-16. doi: 10.1016/j.virol.2009.01.035. Epub 2009 Feb 28.

25.

Development of recombinant varicella-zoster viruses expressing luciferase fusion proteins for live in vivo imaging in human skin and dorsal root ganglia xenografts.

Oliver SL, Zerboni L, Sommer M, Rajamani J, Arvin AM.

J Virol Methods. 2008 Dec;154(1-2):182-93. doi: 10.1016/j.jviromet.2008.07.033. Epub 2008 Sep 24.

26.

Serotype 1 and 2 bovine noroviruses are endemic in cattle in the United kingdom and Germany.

Oliver SL, Wood E, Asobayire E, Wathes DC, Brickell JS, Elschner M, Otto P, Lambden PR, Clarke IN, Bridger JC.

J Clin Microbiol. 2007 Sep;45(9):3050-2. Epub 2007 Jun 27.

27.
28.

Complete genomic characterization and antigenic relatedness of genogroup III, genotype 2 bovine noroviruses.

Oliver SL, Asobayire E, Charpilienne A, Cohen J, Bridger JC.

Arch Virol. 2007 Feb;152(2):257-72. Epub 2006 Oct 25.

PMID:
17066248
29.

Characterization of a cross-reactive linear epitope in human genogroup I and bovine genogroup III norovirus capsid proteins.

Batten CA, Clarke IN, Kempster SL, Oliver SL, Bridger JC, Lambden PR.

Virology. 2006 Dec 5-20;356(1-2):179-87. Epub 2006 Aug 24.

30.

Genomic characterization of the unclassified bovine enteric virus Newbury agent-1 (Newbury1) endorses a new genus in the family Caliciviridae.

Oliver SL, Asobayire E, Dastjerdi AM, Bridger JC.

Virology. 2006 Jun 20;350(1):240-50. Epub 2006 Mar 30.

31.

Genotype 1 and genotype 2 bovine noroviruses are antigenically distinct but share a cross-reactive epitope with human noroviruses.

Oliver SL, Batten CA, Deng Y, Elschner M, Otto P, Charpilienne A, Clarke IN, Bridger JC, Lambden PR.

J Clin Microbiol. 2006 Mar;44(3):992-8.

32.
33.

Molecular characterization of bovine enteric caliciviruses: a distinct third genogroup of noroviruses (Norwalk-like viruses) unlikely to be of risk to humans.

Oliver SL, Dastjerdi AM, Wong S, El-Attar L, Gallimore C, Brown DW, Green J, Bridger JC.

J Virol. 2003 Feb;77(4):2789-98.

34.

Dancing with angels.

Oliver SL.

Am J Hosp Palliat Care. 2000 Nov-Dec;17(6):368. No abstract available.

PMID:
11886033
35.
36.

Painting pictures we cannot see.

Oliver SL.

Am J Hosp Palliat Care. 1996 Sep-Oct;13(5):39-40. No abstract available.

PMID:
8936201
37.

Mood and lithium in drinking water.

Oliver SL, Comstock GW, Helsing KJ.

Arch Environ Health. 1976 Mar-Apr;31(2):92-5.

PMID:
1259475
38.

Chemical modification of human lysozyme. Acetylation and nitration of tyrosine.

Fawcett RI, Limbird TJ, Oliver SL, Borders CL Jr.

Can J Biochem. 1971 Jul;49(7):816-21. No abstract available.

PMID:
5557892
39.

Weight gain, protein utilization, and liver histochemistry of rats fed low- and high-thioglucoside-content rapeseed meals.

Oliver SL, McDonald BE, Opuszyńska T.

Can J Physiol Pharmacol. 1971 May;49(5):448-56. No abstract available.

PMID:
4256276

Supplemental Content

Loading ...
Support Center